nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice
|
Denorme, Frederik |
|
|
127 |
19 |
p. 2337-2345 |
artikel |
2 |
Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutation
|
Mascarenhas, Maria I. |
|
|
127 |
19 |
p. 2298-2309 |
artikel |
3 |
Anti–factor VIII IgA as a potential marker of poor prognosis in acquired hemophilia A: results from the GTH-AH 01/2010 study
|
Tiede, Andreas |
|
|
127 |
19 |
p. 2289-2297 |
artikel |
4 |
Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis
|
Weiss, Brendan M. |
|
|
127 |
19 |
p. 2275-2280 |
artikel |
5 |
Context matters in MLL-AF9–driven leukemias
|
Park, Christopher Y. |
|
|
127 |
19 |
p. 2268-2269 |
artikel |
6 |
Desai RG, Fulton GP. Evidence for a vessel wall defect in immuno-thrombocytopenic hamsters. Blood. 1960;15(5): 675-680.
|
|
|
|
127 |
19 |
p. 2265 |
artikel |
7 |
Development and validation of a rapid, aldehyde dehydrogenase bright–based cord blood potency assay
|
Shoulars, Kevin |
|
|
127 |
19 |
p. 2346-2354 |
artikel |
8 |
Differential role of Id1 in MLL-AF9–driven leukemia based on cell of origin
|
Man, Na |
|
|
127 |
19 |
p. 2322-2326 |
artikel |
9 |
Dissecting stroke for anti-VWF therapeutics
|
Dong, Jing-fei |
|
|
127 |
19 |
p. 2271-2272 |
artikel |
10 |
Editorial Board
|
|
|
|
127 |
19 |
p. i |
artikel |
11 |
Emerging roles for hemostatic dysfunction in malaria pathogenesis
|
O'Sullivan, Jamie M. |
|
|
127 |
19 |
p. 2281-2288 |
artikel |
12 |
Establishing the UCB graft potentiality
|
Wagner, John E. |
|
|
127 |
19 |
p. 2272-2274 |
artikel |
13 |
High-Jaking the blood: resistance is fetal
|
Taoudi, Samir |
|
|
127 |
19 |
p. 2267-2268 |
artikel |
14 |
Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia
|
Wanquet, Anne |
|
|
127 |
19 |
p. 2356-2358 |
artikel |
15 |
Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice
|
Nai, Antonella |
|
|
127 |
19 |
p. 2327-2336 |
artikel |
16 |
Matriptase-2 links erythropoietin to iron
|
Bartnikas, Thomas Benedict |
|
|
127 |
19 |
p. 2270-2271 |
artikel |
17 |
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma
|
Lendvai, Nikoletta |
|
|
127 |
19 |
p. 2355-2356 |
artikel |
18 |
Plasma cell leukemia mimicking acute myeloid leukemia
|
Moore, Erika M. |
|
|
127 |
19 |
p. 2359 |
artikel |
19 |
Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL
|
Shukla, Ashima |
|
|
127 |
19 |
p. 2310-2321 |
artikel |